Page 101 - BH-2-3
P. 101

Brain & Heart                                                                 L2-hydroxyglutaric aciduria



































                      Figure 4. Urine organic acid chromatogram depicting a massive peak corresponding to 2-hydroxyglutaric acid (red arrow)

            Table 1. General biochemical and hematological       In this case, the detection of a massive peak
            investigations                                     corresponding to 2HG in the GC/MS-based UOA
                                                               chromatogram stood as the first clue for the diagnosis
            Analyte         Result  Reference range  Unit      of L2HGA. At the time of writing this paper, facilities
            Full blood count                                   to perform biochemical tests for detecting the absolute
             WBC            10.9    4,000 - 1,100  ×10 /µL     configuration of D and L forms were not available in Sri
                                                     3
             Neutrophils    41%     N/A            N/A         Lanka; therefore, we were facing challenges during the
             Hemoglobin     12.4    11 – 16        g/dL        diagnostic process. In children presenting with learning
             Platelets      260     150 – 350      ×10 /µL     disability and neurological involvement, performing UOA
                                                     3
            AST             51      9 – 48         U/L         analysis will be helpful to avoid missing out on diagnosis
            ALT             14      10 – 40        U/L         of rare diseases like 2-hydroxyglutaric aciduria (2-OHGA)
            ALP             237     60 – 425       U/L         because such diseases necessitate early therapy before
            Sodium          134     135 – 145      mmol/L      significant neurological damage is established.
            Potassium       5.5     3.5 – 5.3      mmol/L        The genetic analysis in this case was performed by
            Creatinine      53      40 – 60        µmol/L      CENTOGENE GmbH, Germany, which identified two
                                                               heterozygous pathogenic variants in the L2HGDH gene: a
            Urea            4.2     1.8 – 6.4      mmol/L
            Uric acid       215     119 – 327      µmol/L      missense variant in exon 3, c.293A>G p.(His98Arg), which
                                                               causes an amino acid change from His to Arg at position 98;
            CPK             237     30 – 150       U/L         and a non-sense variant in exon 7, c.829c>T p.(Arg277٭),
            Total cholesterol  4.4  3.6 – 5.7      mmol/L      which creates a premature stop codon. These findings
            Triglycerides   0.5     0.4 – 1.8      mmol/L      confirmed the diagnosis of autosomal recessive L2HGA
            Abbreviations: ALP: Alkaline phosphatase; ALT: Alanine transaminase;   following the verification of compound heterozygosity in
            AST: Aspartate transaminase; CPK: Creatine phosphokinase; WBC:   parental testing. Several cases of L2HGA due to compound
            White blood cells; N/A: Not applicable.
                                                               heterozygosity have already been reported in the literature.
                                                               No clinically relevant variants were identified in other
            performed to rule out other disorders, such as juvenile   genes.
            Canavan disease, which is a neurodegenerative disorder
            characterized by macrocephaly, abnormal tone, and    Topcu et al. reported that the L2HGDH gene consists
            neurodevelopmental delay. 11                       of 70 variants, including 18 recurrent variants occurring


            Volume 2 Issue 3 (2024)                         5                                doi: 10.36922/bh.2145
   96   97   98   99   100   101   102   103   104   105   106